Accuray, Inc. (ARAY) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1149741,
    "name": "Accuray, Inc.",
    "stock_name": "Accuray, Inc.",
    "full_name": "Accuray, Inc.",
    "name_url": "stocks-analysis/accuray-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "1.02",
    "chg": -0.01,
    "chgp": "-0.97%",
    "dir": -1,
    "prev_price": "1.03",
    "mcapval": "174.65",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US0043971052",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.63 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/accuray-inc-1149741-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Accuray, Inc. Hits 52-Week Low at USD 1.10 Amidst Declining Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/accuray-inc-hits-52-week-low-at-usd-110-amidst-declining-performance-3680173",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AccurayInc_priceRelatedfactors_3680173.png",
        "date": "2025-11-07 16:06:01",
        "description": "Accuray, Inc. has reached a new 52-week low, reflecting ongoing challenges in the Pharmaceuticals & Biotechnology sector. The company has seen a significant stock price decline over the past year, coupled with high debt levels and modest returns on capital, despite a notable increase in profits."
      },
      {
        "title": "Is Accuray, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-accuray-inc-technically-bullish-or-bearish-3546562",
        "imagepath": "",
        "date": "2025-09-20 19:35:45",
        "description": "As of 8 July 2025, the technical trend for Accuray, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a combination of indicators. The MACD is mildly bullish on the weekly chart but bearish on the monthly, while the RSI is bearish on the weekly and shows no signal on the monthly. Moving averages indicate a mildly bearish trend on the daily timeframe. Bollinger Bands are bullish weekly but mildly bearish monthly. KST and Dow Theory both show mildly bullish signals on the weekly and monthly charts.\n\nIn terms of performance, Accuray has underperformed the S&P 500 across multiple periods, with a year-to-date return of -12.12% compared to the S&P 500's 12.22%, and a 1-year return of -8.90% versus 17.14% for the benchmark...."
      },
      {
        "title": "Is Accuray, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-accuray-inc-overvalued-or-undervalued-3543109",
        "imagepath": "",
        "date": "2025-09-20 18:10:51",
        "description": "As of 13 August 2025, the valuation grade for Accuray, Inc. has moved from attractive to risky, indicating a shift in its financial outlook. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 2.68 and an EV to EBITDA of 14.26, which are relatively high compared to its peers. Additionally, the company's Return on Capital Employed (ROCE) stands at a modest 6.87%, while its Return on Equity (ROE) is negative at -0.73%, further highlighting its financial struggles.\n\nIn comparison to its peers, Accuray's EV to EBITDA ratio of 14.26 is significantly lower than that of AngioDynamics, Inc. at 226.06, but higher than Tactile Systems Technology, Inc. at 9.59, which is rated fair. The stock has underperformed against the S&P 500 over multiple periods, with a year-to-date return of -12.12% compared to the S&P 500's 12.22%. This underperformance reinforces the noti..."
      }
    ],
    "total": 8,
    "sid": "1149741",
    "stock_news_url": "https://www.marketsmojo.com/news/accuray-inc-1149741"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Accuray, Inc. Hits 52-Week Low at USD 1.10 Amidst Declining Performance

2025-11-07 16:06:01

Accuray, Inc. has reached a new 52-week low, reflecting ongoing challenges in the Pharmaceuticals & Biotechnology sector. The company has seen a significant stock price decline over the past year, coupled with high debt levels and modest returns on capital, despite a notable increase in profits.

Is Accuray, Inc. technically bullish or bearish?

2025-09-20 19:35:45

As of 8 July 2025, the technical trend for Accuray, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by a combination of indicators. The MACD is mildly bullish on the weekly chart but bearish on the monthly, while the RSI is bearish on the weekly and shows no signal on the monthly. Moving averages indicate a mildly bearish trend on the daily timeframe. Bollinger Bands are bullish weekly but mildly bearish monthly. KST and Dow Theory both show mildly bullish signals on the weekly and monthly charts. In terms of performance, Accuray has underperformed the S&P 500 across multiple periods, with a year-to-date return of -12.12% compared to the S&P 500's 12.22%, and a 1-year return of -8.90% versus 17.14% for the benchmark....

Is Accuray, Inc. overvalued or undervalued?

2025-09-20 18:10:51

As of 13 August 2025, the valuation grade for Accuray, Inc. has moved from attractive to risky, indicating a shift in its financial outlook. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 2.68 and an EV to EBITDA of 14.26, which are relatively high compared to its peers. Additionally, the company's Return on Capital Employed (ROCE) stands at a modest 6.87%, while its Return on Equity (ROE) is negative at -0.73%, further highlighting its financial struggles. In comparison to its peers, Accuray's EV to EBITDA ratio of 14.26 is significantly lower than that of AngioDynamics, Inc. at 226.06, but higher than Tactile Systems Technology, Inc. at 9.59, which is rated fair. The stock has underperformed against the S&P 500 over multiple periods, with a year-to-date return of -12.12% compared to the S&P 500's 12.22%. This underperformance reinforces the noti...

View All News